Uncategorized

Antengene Corporation Limited announced that the latest results from the Phase I/II TORCH-2 study will be presented as a poster at the 2023 American Society for Clinical Oncology Annual Meeting taking place from June 2nd to 6th, 2023 at the McCormick Place Convention Center in Chicago, IL.

Sobre el secreto de los buenos especialistas y su capacidad comunicativa

The Massachusetts-based biopharma became the second company this week to drop its amyotrophic lateral sclerosis hopeful after it failed to elicit significant improvement compared with placebo. 

The Kaiser Family Foundation survey found many enrollees weren’t sure whether states are now allowed to remove people from the program, and 27% wouldn’t know where to look for coverage if they ineligible for Medicaid.

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) (“CNS” or the “Company”) today announced that its ongoing potentially pivotal study evaluating Berubicin for the treatment of recurrent glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer, has enrolled 134 patients, representing more than 50% of the total planned enrollment for the study.

Epic continues to be the EHR market leader, covering 36% of acute care hospitals in the U.S. and 48% of beds, according to a new report.

The decision to replace board chair John Thompson could change the company’s course as it decides whether to divest liquid biopsy company Grail.

A lo largo de la vida, las células están sometidas a diferentes fuentes de estrés ambiental, como la radiación solar, que hacen que se acumulen defectos. Al llegar a cierto nivel de daños, se activan mecanismos de defensa para evitar que pueda desarrollarse un tumo …

The tubeless, disposable insulin patch made by EOFlow will be integrated into Medtronic’s MiniMed 780G system.

The device records the sounds of the patient’s respiratory and cardiac functions and monitors blood oxygen levels to assess suspected obstructive sleep apnea.